Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin.61, 69–90 (2011).
   PubMed Web of Science ®Google Scholar
• Siegel R, Ward E, Brawkey O, Jamal A. Cancer statistics 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer death. CA Cancer J. Clin.61, 212–236 (2011).
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum. Pathol.37, 1371–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Muscheck M, Abol-Enein H, Chew K et al. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis21, 1721–1726 (2000).
   PubMed Web of Science ®Google Scholar
• Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science258, 818–821 (1992).
   PubMed Web of Science ®Google Scholar
• Zarzour AH, Selim M, Abd-Elsayed AA, Hameed DA, Abdelaziz MA. Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics. BMC Cancer8, 250–255 (2008).
   PubMedGoogle Scholar
• Cheng L, Davidson D, Mac Lennan GT et al. The origin of urothelial cancer. Expert Rev. Anticancer Ther.10(6), 865–880 (2010).
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhang D. Molecular Genetic Pathology. Humana Press/Springer, NY, USA (2008).
   Google Scholar
• Sandberg AA, Meloni-Ehrig AM. Cytogenetics and genetics of human cancer: methods and accomplishments. Cancer Genet. Cytogenet.203(2), 102–126 (2010).
   PubMedGoogle Scholar
• Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J. Intern. Med.248, 171–183 (2000).
   PubMed Web of Science ®Google Scholar
• Fried B, Reddy A, Mayer D. Helminths in human carcinogenesis. Cancer Lett.305(2), 239–249 (2011).
   PubMed Web of Science ®Google Scholar
• Ross AGP, Bartly PB, Sleigh AC et al. Schistosomiasis. N. Engl. J. Med.346(16), 1212–1220 (2002).
   PubMed Web of Science ®Google Scholar
• Ferguson AR. Associated bilharziasis and primary malignant disease of the urinary bladder with observations on a series of forty cases. J. Pathol. Bacteriol.16, 76–94 (1911).
   Google Scholar
• Ministry of Health and Population, Egypt, Department of Endemic Diseases. Prevalence of Schistosomiasis in Egypt Over Time (2004).
   Google Scholar
• Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J. Egypt. Natl Canc. Inst.19(2), 158–162 (2007).
   PubMedGoogle Scholar
• Rosin MP, Saad el Din Zaki S, Ward AJ, Anwar WA. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat. Res.305, 83–92 (1994).
   Google Scholar
• Marletta MA. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem. Res. Toxicol.1, 249–257 (1988).
   PubMed Web of Science ®Google Scholar
• Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int.93, 216–220 (2004).
   PubMed Web of Science ®Google Scholar
• Tricker AR, Mostafa MH, Spiegelhalder B, Preussmann R. Urinary excretion of nitrate, nitrite and N-nitroso compounds in schistosomiasis and bilharzial bladder cancer patients. Carcinogenesis10, 547–552 (1989).
   PubMed Web of Science ®Google Scholar
• WHO International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes and Helicobacter pylori. WHO International Agency for Research on Cancer, Lyon, France, 9–175 (1994).
   Google Scholar
• Smith JH, Christie JD. The pathobiology of Schistosoma haematobium infection in humans. Hum. Pathol.17, 333–345 (1986).
   PubMed Web of Science ®Google Scholar
• El-Bolkainy MN, Mokhtar NM, Ghonim MA, Hussein MH. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer48, 2643–2648 (1981).
   PubMed Web of Science ®Google Scholar
• Abdel MM, Hassan A, El-Sewedy S. Human bladder cancer, schistosomiasis, N-nitroso compounds and their precursors. Int. J. Cancer88, 682–683 (2000).
   PubMed Web of Science ®Google Scholar
• Gentile JM. Schistosome related cancers: a possible role for genotoxins. Environ. Mutagen.7, 775–785 (1985).
   PubMedGoogle Scholar
• Botelho M, Ferreia AC, Olivieira MJ, Domingues A, Machado JC, de Costa JM. Schistosoma haematobium total antigen and decreased apoptosis of normal epithelial cells. Int. J. Parasitol.39, 1083–1091 (2009).
   PubMed Web of Science ®Google Scholar
• Wu XR. Urothelial tumorigenesis: a tale of divergent pathway. Nat. Rev. Cancer5, 713–725 (2005).
   PubMed Web of Science ®Google Scholar
• Botelho MC, Machado JC, deCosta JM. Schistosoma haematobium and bladder cancer. Virulence1(2), 84–87 (2010).
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J. Clin.60(4), 244–272 (2010).
   PubMed Web of Science ®Google Scholar
• McConkey DJ, Lee S, Choi W et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol. Oncol.28(4), 429–440 (2010).
   PubMed Web of Science ®Google Scholar
• Abdel Wahab AH, Abo-Zeid HI, El-Husseini MI, Ismail M, El-Khor AM. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder. J. Egypt. Natl Canc. Inst.17(4), 260–269 (2005).
   PubMedGoogle Scholar
• Chaudhary KS, Lu KS, Abel PD et al. Expression of BCL-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of the urinary bladder. Br. J. Urol.79, 78–84 (1997).
   PubMedGoogle Scholar
• El-Sheikh SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani EN. Cyclooxygenase-2: a possible target in schistosoma associated bladder cancer. Br. J. Urol.88, 921–927 (2001).
   Google Scholar
• Hodder SL, Mahmoud AA, Sorenson K et al. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am. J. Trop. Med. Hyg.63, 133–138 (2000).
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Oncogene17, 3021–3027 (1998).
   PubMed Web of Science ®Google Scholar
• Fadl-Elmula I, Kytola S, Leithy ME et al. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer2, 5 (2002).
   PubMed Web of Science ®Google Scholar
• Armengol G, Eissa S, Lozano JJ et al. Genomic imbalances in schistosoma-associated and non schistosoma-associated bladder carcinoma: an array comparative genomic hybridization analysis. Cancer Genet. Cytogenet.177, 16–19 (2007).
   PubMedGoogle Scholar
• Vauhkonen H, Bohling T, Eissa S, Shoman S, Knuutila S. Can bladder adenocarcinomas be distinguished from schistosomiasis associated bladder cancer by using comparative genomic hybridization analysis? Cancer Genet. Cytogenet.177, 153–157 (2007).
   PubMedGoogle Scholar
• Koraitim MM, Metwalli NE, Atta MA, El-Sadr AA. Changing age incidence and pathological types of schistosoma-associated bladder carcinoma. J. Urol.154, 1714–1716 (1995).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, Nouh A, Moneer M, El-Baradie M, Nazmy M, Younis A. Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer. J. Egypt. Natl Canc. Inst.20(2), 168–174 (2008).
   PubMedGoogle Scholar
• Zaghloul MS. Radiation as adjunctive therapy to cystectomy for bladder cancer. Is there a difference for bilharzial association? Int. J. Radiat. Oncol. Biol. Phys.28, 783 (1994).
   PubMedGoogle Scholar
• Zaghloul MS. Distant metastasis from bilharzial bladder cancer. Cancer77, 743–749 (1996).
   PubMed Web of Science ®Google Scholar
• Miller LS. Bladder cancer. Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer39, 973–980 (1977).
   PubMed Web of Science ®Google Scholar
• Werf-Messing BV, Friedell GH, Menon RS, Raigopa SM. Carcinoma of the urinary bladder T3 Nx MO treated by preoperative irradiation followed by simple cystectomy. Int. J. Radiat. Oncol. Biol. Phys.8, 1849–1855 (1982).
   PubMed Web of Science ®Google Scholar
• Greven KM, Spera JA, Solin LW. Local recurrence after cystectomy alone for bladder carcinoma. Cancer69, 2767–2770 (1992).
   PubMed Web of Science ®Google Scholar
• Visser O, Nieuwenhuijzen JA, Horenblas S. Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater Amsterdam. J. Urol.174, 97–102 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng L, Weaver AL, Leibovich BC et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer88, 2326–2332 (2000).
   PubMed Web of Science ®Google Scholar
• Volkmer BG, Kuefer R, Bartsch GC Jr et al. Oncological followup after radical cystectomy for bladder cancer – is there any benefit? J. Urol.181(4), 1587–1593 (2009).
   PubMed Web of Science ®Google Scholar
• Gupta NP, Kolla SB, Seth A et al. Radical cystectomy for bladder cancer: a single center experience. Indian J. Urol.24(1), 54–59 (2008).
   PubMedGoogle Scholar
• El-Said A, Omar S, Ibrahim AS et al. Bilharzial bladder cancer in Egypt. A review of 420 cases of radical cystectomy. Jpn J. Clin. Oncol.9, 117–122 (1979).
   Web of Science ®Google Scholar
• Zaghloul MS, Awwad HK, Omar S et al. Postoperative radiotherapy of carcinoma in bilharzial bladder. Improved disease-free survival through improving local control. Int. J. Radiat. Oncol. Biol. Phys.22, 511–517 (1992).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS. Adjuvant radiation therapy for locally advanced bladder cancer. US Oncol. Dis.2, 86–89 (2006).
   Google Scholar
• Ghoneim MA, El-Mekresh MM, El-Baz MA, El-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J. Urol.158, 393–399 (1997).
   PubMed Web of Science ®Google Scholar
• Ghoneim MA, Abdel-Latif M, el-Mekresh M et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J. Urol.180(1), 121–127 (2008).
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19, 666–675 (2001).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS. Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited. Future Oncol.6(7), 1177–1191 (2010).
   PubMed Web of Science ®Google Scholar
• Gschwend JE, Dahm P, Fair WR. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur. Urol.41(4), 440–448 (2002).
   PubMed Web of Science ®Google Scholar
• Takahashi A, Tsukamoto T, Tobisu K et al. Radical cystectomy for invasive bladder cancer, results of multi-institutional pooled analysis. Jpn J. Clin. Oncol.34, 14–19 (2004).
   PubMed Web of Science ®Google Scholar
• Rogers CG, Palapattu GS, Shariat SF et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma for the bladder compared with transitional cell carcinoma of the bladder. J. Urol.175, 2048–2053 (2006).
   PubMed Web of Science ®Google Scholar
• Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology73, 822–827 (2009).
   PubMed Web of Science ®Google Scholar
• Ploeg M, Aben KK, Hulsbergen-van de Kaa CA et al. Clinical epidemiology of nonurothelial bladder cancer: analysis of The Netherlands Cancer Registry. J. Urol.183(3), 915–920 (2010).
   PubMed Web of Science ®Google Scholar
• Awwad HK, Baki HA, El Bolkainy et al. Preoperative irradiation of T3 carcinoma in bilharzial bladder. Int. J. Radiat. Oncol. Biol. Phys.5, 787–794 (1979).
   PubMed Web of Science ®Google Scholar
• Ghoneim MA, Ashamalla AG, Awwad HK, Whitmore WF Jr. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J. Urol.134, 266–268 (1985).
   PubMed Web of Science ®Google Scholar
• Huncharek M, Muscat J, Geschwind JF. Planned preoperative radiation therapy in muscle invasive bladder cancer. Results of metaanalysis. Anticancer Res.18, 1931–1934 (1998).
   PubMed Web of Science ®Google Scholar
• Reisinger S, Mohiuddin M, Mulholland S. Combined pre- and post-operative adjuvant radiation therapy for bladder cancer – a ten year experience. Int. J. Radiat. Oncol. Biol. Phys.24, 463–468 (1992).
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Pelegrini D, Fallini M et al. Reappraisal of the role of adjuvant radiotherapy in muscle-invasive transitional cell carcinoma of the bladder. Int. J. Radiat. Oncol. Biol. Phys.45, 221 (1999).
   Google Scholar
• Zaghloul MS, Mohran TZ, Saber RA, Agha N. Postoperative radiotherapy in bladder cancer. J. Egypt. Natl Cancer Inst.14, 161–168 (2002).
   Google Scholar
• Zaghloul MS, Nouh A, Nazmy M et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol. Oncol.24, 13–20 (2006).
   PubMed Web of Science ®Google Scholar
• El-Moneim HA, El-Baradie MM, Younis A, Ragab Y, Labib A, El-Attar I. A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer. Urol. Oncol. doi:10.1016/j.urolonc.2011.01.008 (2011) (Epub ahead of print).
   Google Scholar
• Vaughn DJ, Malkowicz SB. Neoadjuvant chemotherapy in patients with invasive bladder cancer. Urol. Clin. North Am.32, 231–237 (2005).
   PubMed Web of Science ®Google Scholar
• Winquist E, Kichner TS, Segal R et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J. Urol.171, 561–569 (2004).
   PubMed Web of Science ®Google Scholar
• Vale CL. Advanced bladder cancer meta-analysis collaboration. Adjuvant chemotherapy for invasive bladder cancer. Cochrane Database Syst. Rev.CD006018 (2006).
   Google Scholar
• Ruggeri EM, Giannarelli D, Bria E et al. Adjuvant chemotherapy in muscle-invasive bladder cancer: a pooled analysis from Phase III studies. Cancer106, 783–788 (2006).
   PubMed Web of Science ®Google Scholar
• Khaled H, Zaghloul M, Ghoneim M et al. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive bladder cancer: effect on bladder preservation and survival. Proc. Am. Soc. Clin. Oncol.22, 411 (2003) (Abstract 1652).
   Google Scholar
• Rödel C. Current status of radiation therapy and combined-modality treatment for bladder cancer. Strahlenther Onkol.180(11), 701–709 (2004).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, Mousa AG. Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results? Expert Rev. Anticancer Ther.10(12), 1933–1944 (2010).
   PubMed Web of Science ®Google Scholar
• Kachnic LA, Kaufman DS, Heney NM et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J. Clin. Oncol.15(3), 1022–1029 (1997).
   PubMed Web of Science ®Google Scholar
• Shipley WU, Winter KA, Kaufman DS et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J. Clin. Oncol.16(11), 3576–3583 (1998).
   PubMed Web of Science ®Google Scholar
• Arias F, Domínguez MA, Martínez E et al. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Int. J. Radiat. Oncol. Biol. Phys.47(2), 373–378 (2000).
   PubMed Web of Science ®Google Scholar
• Tester W, Porter A, Asbell S et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int. J. Radiat. Oncol. Biol. Phys.25(5), 783–790 (1993).
   PubMed Web of Science ®Google Scholar
• Sauer R, Birkenhake S, Kühn R, Wittekind C, Schrott KM, Martus P. Efficacy of radiochemotherapy with platin derivatives compared with radiotherapy alone in organ-sparing treatment of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys.40(1), 121–127 (1998).
   PubMed Web of Science ®Google Scholar
• Sabaa MA, El-Gamal OM, Abo-Elenen M, Khanam A. Combined modality treatment with bladder preservation for muscle invasive bladder cancer. Urol. Oncol.28, 14–20 (2010).
   PubMed Web of Science ®Google Scholar
• Bassi P, Ferrante GD, Piazza N et al. Prognostic factors of outcome after radical cystectomy for bladder cancer, a retrospective study of homogenous patient cohort. J. Urol.161, 1494–1497 (1999).
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Palapattu GS. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J. Urol.176(6), 2414–2422 (2006).
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Sun M, Jeldres C et al. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology75(2), 376–381 (2010).
   PubMed Web of Science ®Google Scholar
• El-Mekresh MM, el-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br. J. Urol.82(2), 206–212 (1998).
   PubMedGoogle Scholar
• Khaled H, El-Hattab O, Moneim DA, Kassem HA, Morsi A, Sherif G. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer. Urol. Oncol.23, 254–260 (2005).
   PubMed Web of Science ®Google Scholar
• Ali-El-Dein B. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women. Eur. J. Surg. Oncol.35(3), 320–325 (2009).
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today: a homogeneous series without neoadjuvant therapy. J. Clin. Oncol.21, 690–669 (2003).
   PubMed Web of Science ®Google Scholar
• Dhar NB, Campbell SC, Zippe CD et al. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. BJU Int.98(6), 1172–1175 (2006).
   PubMed Web of Science ®Google Scholar
• Ho CH, Huang CY, Lin WC et al. Radical cystectomy in the treatment of bladder cancer: oncological outcome and survival predictors. J. Formos. Med. Assoc.108(11), 872–878 (2009).
   PubMed Web of Science ®Google Scholar
• Manoharan M, Ayyathurai R, Soloway MS. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome. BJU Int.104(9), 1227–1232 (2009).
   PubMed Web of Science ®Google Scholar
• Nishiyama H, Habuchi T, Watanabe J et al. Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990–2000 in Japan. Eur. Urol.45, 176–181 (2004).
   PubMed Web of Science ®Google Scholar
• Niu HT, Xu T, Zhang YB et al. Outcomes for a large series of radical cystectomies for bladder cancer. Eur. J. Surg. Oncol.34(8), 911–915 (2008).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, El Baradie Nouh MA, Abdel-Fatah S, Taher A, Shalaan M. Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J. Oncol.1(2), 47–54 (2007).
   Google Scholar